高级检索
当前位置: 首页 > 详情页

Clinical Features and Prognosis of Young and Middle-Aged Adults With Skin Sebaceous Adenocarcinoma

文献详情

资源类型:
Pubmed体系:
机构: [1]Department of Dermatology and Venerology, National Clinical Research Center for Geriatrics, Sichuan University West China Hospital, Chengdu, China [2]Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology (CIII), Frontiers Science Center for Disease-Related Molecular Network, Sichuan University West China Hospital, Chengdu, China [3]Department of Abdominal Cancer, Sichuan University West China Hospital, Chengdu, China
出处:
ISSN:

摘要:
Sebaceous adenocarcinoma (SAC) mostly occurs in the elderly, and SAC in young and middle-aged population is inadequately investigated.To explore the clinical features and prognosis of young and middle-aged adults with SAC.Patients with skin SAC between ages 18 and 59 years from the Surveillance, Epidemiology, and End Results database (1975-2016) were eligible for this study.Seven hundred thirty-nine cases were identified. The proportion of extraocular SAC in the nonelderly increased from 1975-2005 to 2006-2016 ( p = .001), male predominance was observed in overall patients whereas female predominance in Asian population, and young patients had more head and neck SAC than middle-aged patients ( p = .014). The prognosis of young patients was better than middle-aged patients ( p = .004). Other independent prognostic factors included sex, marital status, tumor size, surgery, chemotherapy, and multiple primary cancer history.An increasing proportion of extraocular SAC was observed in young and middle-aged patients, and the young developed more head and neck SAC than the middle-aged. Female predominance was found in Asian population, and female patients had better prognosis. Younger age and married status indicated better prognosis, and around 20% of young and middle-aged patients might have poorer survival because of Muir-Torre syndrome.Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Society for Dermatologic Surgery, Inc.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类 | 3 区 医学
小类 | 3 区 皮肤病学 3 区 外科
最新[2025]版:
大类 | 3 区 医学
小类 | 3 区 皮肤病学 3 区 外科
第一作者:
第一作者机构: [1]Department of Dermatology and Venerology, National Clinical Research Center for Geriatrics, Sichuan University West China Hospital, Chengdu, China [2]Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology (CIII), Frontiers Science Center for Disease-Related Molecular Network, Sichuan University West China Hospital, Chengdu, China
通讯作者:
通讯机构: [1]Department of Dermatology and Venerology, National Clinical Research Center for Geriatrics, Sichuan University West China Hospital, Chengdu, China [2]Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology (CIII), Frontiers Science Center for Disease-Related Molecular Network, Sichuan University West China Hospital, Chengdu, China [*1]Department of Dermatology and Venerology, Sichuan University West China Hospital, Chengdu 610041, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:65780 今日访问量:3 总访问量:5151 更新日期:2025-12-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号